Pharmacovigilance-focused literature screening with Q1/Q2/Q3 classification
Catches class-level safety papers: (drug class/target) AND (safety keywords OR Safety MeSH). No indication terms — class-effect monitoring is indication-agnostic.
Presets for common safety surveillance configurations: